NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.1480
+0.0440 (42.31%)
Nov 20, 2026, 3:57 PM EST
NDT Pharmaceuticals Company Description
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Tulsa, Oklahoma.
NDT Pharmaceuticals Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | James Hovis |
Contact Details
Address: 1207 Lewis AV Tulsa, Oklahoma 74104 United States | |
| Phone | 888-261-9127 |
| Website | ndtpharma.com |
Stock Details
| Ticker Symbol | NDTP |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Reporting Currency | USD |
| ISIN Number | US63948Q1058 |
| SIC Code | 1000 |
Key Executives
| Name | Position |
|---|---|
| James B. Hovis | Acting Chief Executive Officer |
| Robert DeZanger III | Chairman and President |
| Lisa Zuck | Treasurer, Secretary and Director |